Pharmaceuticals

Clinical trials rarely include children; as a result, less than half of all drugs are approved for pediatric use. What can be done?

In the two days since the second U.S. Ebola patient was diagnosed, the U.S. Centers for Disease Control and Prevention (CDC) has assembled a new team to battle the threat of Ebola.

I’m thrilled to report that two Scientific American graphics (on bees and caffeine) are featured in The Best American Infographics 2014.

Infected gorillas and chimps butchered for meat may be behind Ebola outbreaks. David Biello reports

 

Electron microscopy reveals a meshlike protective layer in the viruses that cause herpes and mononucleosis, among other disorders

“Against stupidity, even the gods strive in vain.” — Fredirich Schiller I've been glued to the Ebola news, riding the roller coaster of emotions.

Health authorities in Spain have confirmed that a health worker at the Carlos III Hospital in Madrid, Spain has been infected with the Ebola virus.

A signature science program of the Obama administration’s second term—one intended to develop technologies and a base of knowledge to solve long-standing mysteries of how the brain works—has finally reached cruising altitude.

Too many men are getting testosterone for the wrong reasons

Dallas hospital is treating traveler from Liberia

New data released today will promote transparency and help patients know when docs receive money from product makers

Genetically manipulated yeast can produce morphine that could help get around the problems with poppy crops, which include climate, disease and war. Karen Hopkin reports